Beyond Barriers

A novel technology platform
for the delivery of therapeutics
across biological barriers

TECHNOLOGY INVESTORS
Gate2Brain

The solution

Gate2Brain
Technology

Gate2Brain (G2B) uses a novel technology platform for the delivery of therapeutics. Our platform is based on three families of peptide shuttles that improve the biopharmaceutical properties of cargoes such as small molecules, peptides, nanoparticles, proteins and antibodies in vitro and in vivo when conjugated to them.

The G2B technology platform is applicable to therapeutic areas in which biological barriers hinder the delivery and activity of drugs.

Read more

About us

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We pursue our goals using a radically innovative peptide-based patented technology platform.

Read more
Link to: Technology
Technology

Gate2Brain (G2B) has a proprietary novel technology platform for the delivery of therapeutics across biological barriers.

Link to: Pipeline-Proof of Concept
Pipeline and Therapeutic Proof of Concept

G2B-002, the first therapeutic proof of concept of our technology platform, is aimed mainly at the treatment of rare pediatric solid tumors.

Link to: Investors
Investors

A strong network of investors ensures funding to achieve our goals.

Medicines beyond barriers

We go beyond physiological and disease barriers, as our portfolio of peptide shuttles cover barriers such as the blood-brain,
blood-retinal, skin and tumor barriers. We go beyond economic barriers, such as the lack of investment for the development of pediatric drugs. We go beyond societal barriers to provide medicines for everyone, everywhere.

Clinical Focus

Therapeutic
Proof of Concept

Our G2B therapeutic-peptide shuttle conjugates carry the drug cargo candidates to the target site in which the disease arises. G2B-002, our flagship product and proof of concept of the technology, offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare pediatric cancers.

Our objective is for G2B-002 to reach Phase 1 clinical trials and thus have a high social impact focused on the unmet medical needs of oncology, pediatric and rare diseases.

G2B-002 shows potent preclinical activity for rare pediatric cancer indications such as pediatric high-grade gliomas, DIPG, Ewing sarcoma, rhabdomyosarcoma and neuroblastoma.

READ MORE
Gate2Brain

News & Media

Welcome to our news section, which provides a selection of our coverage in the media, industry, latest developments, plus videos, and more.

StartUBUniversitat de Barcelona

StartUB day

Yesterday, our CEO, Meritxell Teixidó, took part in the StartUB day! event organized by Let's UB!. This…
Read more
Gate2Brain among the 5 Catalan startups that have obtained funding from EIC Acceleratorcanva

Gate2Brain among the 5 Catalan startups that have obtained funding from EIC Accelerator

According to ACCIÓ, Catalonia is the second European region attracting the most funding for deep tech…
Read more
Tides 2023G2B

Tides USA 2023 Oligonucleotide & Peptide Therapeutic

We are back from the west coast, San Diego, from attending Tides USA– Oligonucleotide & Peptide…
Read more
gate2brain finalist south summit 2023south summit

Gate2Brain finalist of the South Summit Madrid

Gate2Brain has been named a finalist in the Health Category of the South Summit Madrid 2023. The event…
Read more
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i Gimpera

Three University of Barcelona spin-offs will receive funding from Women TechEU pilot call

THREE UNIVERSITY OF BARCELONA SPIN-OFFS LED BY WOMEN WILL RECEIVE FUNDING AS PART OF THE WOMEN TechEU…
Read more
Sustainability Policies, Innovation, Entrepreneurship and New Production Models.g2b

Sustainability Policies, Innovation, Entrepreneurship and New Production Models

This week Gate2Brain attended the conference on Sustainability Policies, Innovation, Entrepreneurship…
Read more
https://www.lsxleaders.com/lsx-world-congressG2B

G2B at LSX World Congress 2023

Gate2Brain will be attending the 9th edition of LSX WORLD CONGRESS, Biotech / Healthtech / Medtech, on…
Read more
We’re excited to share that our start-up has been selected as one of @EITHealth 's Catapult 2022-2023 runner-ups. We are looking forward to showcase our health innovation at the 2023 Bits & Pretzels Healthtech event in Munich to a network of top health innovators and compete for the chance to win the Industry Prizes.EIT Health

Finalist Catapult 2022-2023

Gate2Brain has been selected as one of ‌EITHealth 's Catapult 2022-2023 runner-ups. We…
Read more
CataloniaBio & Health Teach GalaG2B

CataloniaBio HT Gala 2023

Yesterday we attended CataloniaBio & Health Tech Gala. We were over 320 entrepreneurs, executives,…
Read more
The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach”, organized by Foment del Treball.Foment del Treball

The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach.

On Tuesday, Wednesday 29, our CEO, Meritxell Teixidó, will participate in the session “The innovative…
Read more
NEWS & MEDIA

1
2
Gate2Brain
1

Making therapies a reality for patients by addressing unmet medical needs.

2

Improving patients’ quality of life using a technology that provides superior drug transport efficacy.

Go Beyond Barriers & Contact Us

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Gate2Brain
Gate2Brain
Gate2Brain
Gate2Brain
Gate2Brain
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social